G1 Therapeutics raises $50M to support commercial, clinical plans


An oncology company in Research Triangle Park has raised new capital to support sales of its sole product and fund development of new cancer drugs.

Previous Mary Frances Burleson, 1935-2022: Longtime president and CEO of Ebby Halliday Cos. dies at 87
Next G1 Therapeutics raises $50M to help lift sales for cancer drug